Matches in Wikidata for { <http://www.wikidata.org/entity/Q68581894> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q68581894 description "article scientifique publié en 1990" @default.
- Q68581894 description "artículu científicu espublizáu en setiembre de 1990" @default.
- Q68581894 description "im September 1990 veröffentlichter wissenschaftlicher Artikel" @default.
- Q68581894 description "scientific article published on 01 September 1990" @default.
- Q68581894 description "wetenschappelijk artikel" @default.
- Q68581894 description "наукова стаття, опублікована у вересні 1990" @default.
- Q68581894 name "High-dose cytosine arabinoside and amsacrine or mitoxantrone in relapsed and refractory acute myeloid leukaemia: a prospective randomized study" @default.
- Q68581894 name "High-dose cytosine arabinoside and amsacrine or mitoxantrone in relapsed and refractory acute myeloid leukaemia: a prospective randomized study" @default.
- Q68581894 type Item @default.
- Q68581894 label "High-dose cytosine arabinoside and amsacrine or mitoxantrone in relapsed and refractory acute myeloid leukaemia: a prospective randomized study" @default.
- Q68581894 label "High-dose cytosine arabinoside and amsacrine or mitoxantrone in relapsed and refractory acute myeloid leukaemia: a prospective randomized study" @default.
- Q68581894 prefLabel "High-dose cytosine arabinoside and amsacrine or mitoxantrone in relapsed and refractory acute myeloid leukaemia: a prospective randomized study" @default.
- Q68581894 prefLabel "High-dose cytosine arabinoside and amsacrine or mitoxantrone in relapsed and refractory acute myeloid leukaemia: a prospective randomized study" @default.
- Q68581894 P1433 Q68581894-8883D3A7-C793-4DCF-8D4C-33321FCE988C @default.
- Q68581894 P1476 Q68581894-DC53B07C-D348-4DE9-9E14-36BBAC0EB0F3 @default.
- Q68581894 P2093 Q68581894-1AD6D523-1927-43D4-84C7-621A88148069 @default.
- Q68581894 P2093 Q68581894-27CA5A29-3661-40C2-B08A-A3CAA56A5186 @default.
- Q68581894 P2093 Q68581894-2AE14FB2-4B98-4007-B3A1-8C0D29488C9E @default.
- Q68581894 P2093 Q68581894-4E1D0350-3AA2-48C1-BE8C-FFC523A67BA6 @default.
- Q68581894 P2093 Q68581894-542151FE-D099-4111-9D50-A0ED05BDA59B @default.
- Q68581894 P2093 Q68581894-74CA8AB0-7CDA-4E1B-9F32-D1B56E387DF5 @default.
- Q68581894 P2093 Q68581894-8A4443A8-C6E0-4D66-90B2-9C88FEA2E435 @default.
- Q68581894 P2093 Q68581894-C23D823F-3145-4419-9D3D-E64D8063F813 @default.
- Q68581894 P2093 Q68581894-D8F2FFC4-C28A-4990-B32D-16398E6E1924 @default.
- Q68581894 P304 Q68581894-0D9FB122-E38B-4DA9-8683-55BFC4D66DAA @default.
- Q68581894 P31 Q68581894-49273D68-CAF5-4A14-A462-E1C3F053A79E @default.
- Q68581894 P356 Q68581894-4EB805BC-3AB2-4352-AE7E-731013479B3D @default.
- Q68581894 P433 Q68581894-D1D160AC-5CBD-47A6-BD25-9EEB53A99863 @default.
- Q68581894 P478 Q68581894-E611EFF8-3738-494F-8EE1-77A874B35023 @default.
- Q68581894 P577 Q68581894-54A3224A-FB3F-41C9-B1CE-63E1EE50BC29 @default.
- Q68581894 P698 Q68581894-2F988241-DE4D-4662-93E0-B8F3F8FBC867 @default.
- Q68581894 P921 Q68581894-E2A7C921-6D0D-4250-B948-8A6FDC09F316 @default.
- Q68581894 P356 J.1600-0609.1990.TB00445.X @default.
- Q68581894 P698 2226729 @default.
- Q68581894 P1433 Q15765799 @default.
- Q68581894 P1476 "High-dose cytosine arabinoside and amsacrine or mitoxantrone in relapsed and refractory acute myeloid leukaemia: a prospective randomized study" @default.
- Q68581894 P2093 "A Bosly" @default.
- Q68581894 P2093 "A Delannoy" @default.
- Q68581894 P2093 "A Ferrant" @default.
- Q68581894 P2093 "C Chatelain" @default.
- Q68581894 P2093 "C Doyen" @default.
- Q68581894 P2093 "G Sokal" @default.
- Q68581894 P2093 "J L Michaux" @default.
- Q68581894 P2093 "J M Ghilain" @default.
- Q68581894 P2093 "P Martiat" @default.
- Q68581894 P304 "164-167" @default.
- Q68581894 P31 Q13442814 @default.
- Q68581894 P356 "10.1111/J.1600-0609.1990.TB00445.X" @default.
- Q68581894 P433 "3" @default.
- Q68581894 P478 "45" @default.
- Q68581894 P577 "1990-09-01T00:00:00Z" @default.
- Q68581894 P698 "2226729" @default.
- Q68581894 P921 Q180983 @default.